News – Page 4 – PD-MitoQUANT

Dr Sinéad O’Sullivan, DZNE presents at August 12th NeuroConnect meeting

pdmq_admin2021-08-09T12:20:59+01:00August 9th, 2021|News, Partner in the Spotlight|

Dr Sinéad O'Sullivan, Humboldt Fellow at the German Center for Neurodegenerative Diseases, the DZNE, will present PD-MitoQUANT findings and her research at the next NeuroConnect meeting, August 12th at 4:00 PM Irish Time. Dr O'Sullivan will present her research on alpha-synuclein induced mitochondrial dysfunction and the role of glial cells in Parkinson's disease. Sinéad's talk entitled 'Modelling alpha-synuclein pathology in vivo' will also include an overview of the pre-clinical models used in the lab: AAV human alpha-synuclein overexpression in the substantia [...]

CNRS Research Director Ronald Melki co-authors comprehensive Alpha-synuclein review in Nature

pdmq_admin2024-06-12T18:24:39+01:00August 5th, 2021|News, Partner in the Spotlight|

Prof Ronald Melki, CNRS Prof. Ronald Melki, Research Director at the CNRS co-authored with several Parkinson's research experts a recent review 'Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease'. The paper's authors are Luis M. A. Oliveira, Thomas Gasser, Robert Edwards, Markus Zweckstetter, Ronald Melki, Leonidas Stefanis, Hilal A. Lashuel, David Sulzer, Kostas Vekrellis, Glenda M. Halliday, Julianna J. Tomlinson, Michael Schlossmacher, Poul Henning Jensen, Julia Schulze-Hentrich, Olaf Riess, Warren D. Hirst, Omar El-Agnaf, Brit [...]

Prof. Ronald Melki, CNRS will speak at Young Scientist Symposium on Protein Quality

pdmq_admin2021-08-09T15:29:06+01:00August 3rd, 2021|News|

Professor Ronald Melki, CNRS will deliver a plenary talk in the Young Scientist Symposium on Protein Quality, September 23rd and 24th. The two-day online meeting aims to provide young scientists (postdocs and PhD students) an attractive and interactive platform to present and discuss their current work with everyone in the field of protein quality control. If you are interested in presenting your work with either a short talk or a flash talk or want to attend this exciting symposium, then [...]

Partners Parkinson’s UK join new ACT-PD (Accelerated Clinical Trials) initiative

pdmq_admin2021-07-09T07:07:59+01:00July 8th, 2021|News, Partner in the Spotlight|

Parkinson's UK Associate Director of Research Prof. David Dexter and PPI volunteer Paula Scurfield, together with some of the research staff at Parkinson's UK are involved in the new ACT-PD (Accelerated Clinical Trials) initiative. Funded by the Edmond J. Safra Foundation, ACT-PD is a 3-year programme that brings together national and international experts to develop a protocol and sustainable strategy for a multi-arm, multi-stage trial platform to investigate disease-modifying therapies in Parkinson’s disease. A Multi-Arm Multi-Stage (or MAMS) clinical trial is a [...]

Welcome to the PD-MitoQUANT team, Anagha!

pdmq_admin2021-06-24T08:01:18+01:00June 24th, 2021|News|

We extend a warm welcome Anagha Jagannathan, MSc. who is working together with Dr Franziska Walter at the RCSI - the University of Medicine and Health Sciences to study mitochondrial stress response and bioenergetics in primary cortical neurons. I am originally from India where I completed my undergraduate degree in genetics. I completed my master's degree in Molecular biology at University College Cork, Ireland and am currently working as a research assistant at RCSI. I have a background in molecular [...]

MIMETAS opens new Phenotypic Screening Center in Leiden

pdmq_admin2021-06-01T07:55:37+01:00June 1st, 2021|News, Partner in the Spotlight|

PD-MitoQUANT partner MIMETAS, the global leader in human-relevant organ-on-a-chip models, opened their new Phenotypic Screening Center on May 27, 2021. The center, located in Leiden, NL facilitates large-scale screening campaigns on Organ-on-a-Chip models, a powerful technology that improves the human physiological relevance of cultured tissues by utilizing microfluidic techniques. MIMETAS OrganoPlate® technology used in the PD-MitoQUANT project offers the scalability and the throughput needed for drug discovery studies. “We are very proud to open up this new center,” said Jos [...]

Save the Date: Parkinson’s UK Excellence Network Conference, November 4th

pdmq_admin2021-05-31T09:41:47+01:00May 31st, 2021|News, Partner in the Spotlight|

Our partners at Parkinson's UK are organizing a 2021 Excellence Network Conference on November 4th, 2021. The online, one-day conference theme is 'Progression beyond the pandemic: what have we learned from coronavirus (COVID-19)?'. Together delegates will learn, share and discuss. The programme will focus on the future and share learning and experiences across the themes of: Restarting life after the pandemic Restarting services after the pandemic Technology Research Exercise The 8:00 AM-6:00 PM conference will assemble health and social care professionals, [...]

Vacancy: PD-MitoQUANT post-doc at the RCSI

pdmq_admin2021-05-11T12:02:07+01:00May 11th, 2021|News|

The following vacancy exists at the RCSI (The Royal College of Surgeons in Ireland – University of Medicine and Health Sciences) in Dublin, Ireland: Title: Post-Doctoral Position Single Cell Imaging and Molecular Neurobiology of Parkinson’s disease (8 months) Department: RCSI Centre for Systems Medicine and SFI Future-Neuro Research Centre, Dept of Physiology and Medical Physics Location: Royal College of Surgeons in Ireland University of Medicine and Health Sciences Term: 8-month specified purpose contract (with the possibility of extension pending EU approval) Reporting to: Prof Jochen [...]

“TP53INP1 exerts neuroprotection under ageing and Parkinson’s disease-related stress condition”

pdmq_admin2021-05-10T16:42:44+01:00May 10th, 2021|News, Publication|

Dr Olga Corti, ICM A PD-MitoQUANT study co-authored by Scientific Co-Leader Dr Olga Corti and PhD student Noemi Asfogo of the Institut du Cerveau – Paris Brain Institute (ICM) was published on May 8th, 2021. The open-access paper entitled: TP53INP1 exerts neuroprotection under ageing and Parkinson’s disease-related stress condition appeared in the journal Cell Death & Disease, a peer-reviewed online journal in the field of translational cell death. Congratulations to all authors! Citation: Dinh, E., Rival, T., Carrier, A. et [...]

Welcome Dr Franziska Walter, a PD-MitoQUANT postdoctoral researcher at the RCSI

pdmq_admin2021-05-04T15:05:01+01:00May 4th, 2021|News|

Welcome to the PD-MitoQUANT project, Dr Franziska Walter! Franziska joins the research team at the RCSI and is very excited to bring her expertise to the PD-MitoQUANT project. Working together with Dr Orla Watters on Tasks 1.3 and 1.4, Franziska conducts reactive oxygen species and bioenergetic measurements in primary neurons. Franziska Walter, PhD is originally from Germany where she completed an undergraduate degree in science. She earned a PhD at the RCSI and currently works as a postdoctoral researcher. Possessing [...]